Which of the following is an adequate definition of quality assurance for the conduct of a clinical trial?

Quality Assurance (QA) in clinical trials refers to the proactive and systematic processes established to ensure the trial is conducted and data are handled in compliance with Good Clinical Practice (GCP) and regulatory standards. It is a process-based approach focused on preventing errors by building quality into the system from the start. This includes developing standard operating procedures (SOPs), training staff, and planning all trial-related activities to meet predefined quality standards, ensuring data integrity and the protection of human subjects.

A. This definition more accurately describes the primary function of an Institutional Review Board (IRB) or an Independent Ethics Committee (IEC), which is focused on the ethical oversight and protection of human subjects.

C. This describes a regulatory inspection or audit, which is a reactive evaluation by an authority (like the FDA) to verify compliance, not the proactive system of QA itself.

D. This describes a specific task of an IRB/IEC. While part of the overall quality system, it is not the comprehensive definition of Quality Assurance, which encompasses all trial processes.

1. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). (2016). Guideline for Good Clinical Practice E6(R2).

Section 1.46 Quality Assurance (QA): "All those planned and systematic actions that are established to ensure that the trial is performed and the data are generated, documented (recorded), and reported in compliance with Good Clinical Practice (GCP) and the applicable regulatory requirement(s)." This definition is a direct match for the correct answer.

2. U.S. Food and Drug Administration (FDA). (2013). Guidance for Industry: Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring.

Section III.A. Quality by Design: The guidance emphasizes building quality into the design and conduct of trials, stating, "The sponsor should... implement a system to manage quality throughout all stages of the clinical trial process." This aligns with the systematic, planned nature of QA.

3. Andrade, A. S., et al. (2019). The role of quality assurance and quality control in the implementation of good clinical practice. Perspectives in Clinical Research, 10(3), 139–141.

DOI: https://doi.org/10.4103/picr.PICR2119

Page 139, Introduction: The article defines QA as "a set of planned and systematic actions to ensure that the clinical trial is conducted, and the data are generated, documented, and reported in compliance with GCP..." This reinforces the definition provided in ICH E6(R2).